Weak D Antigen
Second to ABO, the Rh blood group system is the most recognized with more than 50 antigens, but the D antigen is considered the most important in transfusion medicine. The terms Rh Positive and Rh Negative, respectively, refer to the presence or absence of the D antigen. The name Rh is a misnomer since the system was named after the rhesus monkey when it was believed that an antigen on the red blood cells (RBC) of rhesus monkeys was identical to an antigen on human red blood cells.
The immunogenicity (the likelihood of producing an immune antibody if introduced into a Rh negative recipient) of the D antigen is greater than that of nearly all other RBC antigens. Genes that control the Rh(D) blood group system are autosomal codominant and located on chromosome number one.
To determine the Rh(D) type, patient’s cells are mixed with D antiserum. However, not all D positive cells react equally with anti-D reagent. Thus, additional testing may be required to demonstrate the presence of a weakly expressed D antigen, appropriately known as “weak D.” The variable reactivity of the “weak D” antigen is demonstrated by indirect antiglobulin technique (IAT).
“Weak D” is not considered an antigen separate from the “D” antigen itself but rather a weaker form. The weak D phenotype can arise from several different genetic circumstances: 1) inheritance of D genes that result in lowered densities of D antigens on RBC membranes; 2) the position effect that reflects the interaction between genes; 3) D mosaic where one or more parts of the D antigen are missing.
The transfusion of “weak D” positive RBCs to an individual who is truly Rh negative can illicit an immune response. Thus, transfusion centers and hospitals have developed policies which deal with the “weak D” issue regarding transfusion practices. The safest rule regarding “weak D” is that those who are “weak D” positive should be considered Rh positive as donors and negative as recipients.
- Weak D testing is done to confirm the presence or absence of the D antigen when initial results with D antiserum show negative results
- To confirm D negativity in fetal cord blood of Rh negative mothers
- To confirm D negativity in blood donors
Depends on the indication of use; for prenatal screening (pregnancy) Rh positive results are preferred.
For transfusion, individuals with Rh positive can receive blood from both Rh positive and Rh negative; individuals Rh negative can receive blood only from Rh negative.
Red top (serum) tube or Lavender top (EDTA) tube.
Stability
- Ambient: 24 hours
- Refrigerated: 2 weeks
- Glycoconj J. 2000 Jul-Sep;17(7-9):501-30. [PMID: 11421345]
- Wien Klin Wochenschr. 2001 Oct 30;113(20-21):787-98. [PMID: 11732114]
- Transfus Clin Biol. 1997 Jul;4(4):345-9. [PMID: 9269714]
- Transfusion. 2004;44:703. [PMID: 15104651]
- Whitlock, Sheryl A. Immunohematology for Medical Laboratory Technicians. Delmar, New York, 2010.
- Harmening D. Modern Blood Banking and Transfusion Practices. F.A. Davis, Philadelphia, 2005. Blaney K and Howard P. Basic and Applied Concepts of Immunohematology. Mosby, Philadelphia, 2000.